3648 results for «693»

Filter By

3648 results

DCB, DES, BRS - One fits all or all fit together?

18 May 2023 – From EuroPCR 2023

Check out this session to learn more about polymer-free treatment options with DCB and DES, increasing DCB in the daily cathlab routine, and the possibility of including BRS in the daily PCI routine.

DCB, DES, BRS - One fits

Pivotal momentum for tricuspid valve interventions (Episode 1: the right side)

18 May 2023 – From EuroPCR 2023

Based on an in-depth review of the data from TRILUMINATE pivotal, a randomized trial whose findings were recently published in the NEW ENGLAND JOURNAL of MEDICINE, this lecture explains how these results will impact clinical practice in the treatment of tricuspid regurgitation. Join the speakers and...

Pivotal momentum for

Complications in left main interventions

16 May 2023 – From EuroPCR 2023

How do you recognize the signs of complications during procedures and achieve optimal results? Dive into this collection of cases to see your peers skillfully meet the challenges, learning valuable lessons in the process.

Complications in left main interventions

Innovations in TMVR and Intrepid trial updates

18 May 2023 – From EuroPCR 2023

This session explores the innovations in Transcatheter Mitral Valve replacement, with a special focus on the updates from the INTREPID and APOLLO EU trial, as well as patient benefits through case studies.

Innovations in TMVR and

World Heart Day 2025: the Heart Team beyond the Cathlab

29 Sep 2025

September 29th marks the 25th anniversary of the creation of World Heart Day by the World Heart Federation. This day is dedicated to focusing international attention on cardiovascular disease (CVD), which remains one of the leading causes of mortality worldwide [1,2]. Today, we highlight the women...

World Heart Day 2025 - the Heart Team beyond the Cathlab

RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation

05 Sep 2023

Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.

Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...

Alessandro Sticchi

Author

Alessandro Sticchi
RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation

REC-CAGEFREE I - Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of de novo coronary artery lesions

08 Sep 2024

Mirvat Alasnag provides her take on REC-CAGEFREE I, a multicenter, non-inferiority trial presented at the ESC Congress 2024 in London.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
REC-CAGEFREE I

NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome

02 Sep 2025

Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...

Daniele Giacoppo

Author

Daniele Giacoppo
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
Didn’t find what you were looking for?